Breaking News Instant updates and real-time market news.

MYL

Mylan

$19.67 /

+0.225 (+1.16%)

16:30
05/21/19
05/21
16:30
05/21/19
16:30

FDA: Mylan broadens recall of Valsartan tablets

Mylan N.V.External Link Disclaimer announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets. Reference Link

  • 31

    May

MYL Mylan
$19.67 /

+0.225 (+1.16%)

05/15/19 Wells Fargo
Lawsuit creates overhang for Teva, Mylan, says Wells Fargo
05/13/19 Wells Fargo
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
05/08/19
Fly Intel: Top five analyst downgrades
05/08/19 RBC Capital
Mylan price target lowered to $26 from $45 at RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Cerecor announces publication highlighting the role of LIGHT in COVID-19 ARDS » 07:20
08/13/20
08/13
07:20
08/13/20
07:20
CERC

Cerecor

$2.59 /

-0.17 (-6.16%)

Cerecor announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERC Cerecor
$2.59 /

-0.17 (-6.16%)

CERC Cerecor
$2.59 /

-0.17 (-6.16%)

03/13/20
Fly Intel: Top five analyst downgrades
03/13/20 Maxim
Cerecor downgraded to Hold from Buy at Maxim
01/09/20 Oppenheimer
Cerecor initiated with an Outperform at Oppenheimer
CERC Cerecor
$2.59 /

-0.17 (-6.16%)

  • 09
    Jun
Hot Stocks
TG Therapeutics announces FDA acceptance of NDA for umbralisib » 07:18
08/13/20
08/13
07:18
08/13/20
07:18
TGTX

TG Therapeutics

$19.08 /

+0.6 (+3.25%)

TG Therapeutics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$19.08 /

+0.6 (+3.25%)

TGTX TG Therapeutics
$19.08 /

+0.6 (+3.25%)

08/11/20 Cantor Fitzgerald
TG Therapeutics price target lowered to $30 from $35 at Cantor Fitzgerald
06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
TGTX TG Therapeutics
$19.08 /

+0.6 (+3.25%)

  • 15
    May
TGTX TG Therapeutics
$19.08 /

+0.6 (+3.25%)

TGTX TG Therapeutics
$19.08 /

+0.6 (+3.25%)

Downgrade
Corporate Office Properties downgraded to Neutral from Outperform at Baird » 07:18
08/13/20
08/13
07:18
08/13/20
07:18
OFC

Corporate Office Properties

$26.20 /

+0.135 (+0.52%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OFC Corporate Office Properties
$26.20 /

+0.135 (+0.52%)

OFC Corporate Office Properties
$26.20 /

+0.135 (+0.52%)

07/09/20 KeyBanc
Corporate Office Properties upgraded to Sector Weight from Underweight at KeyBanc
07/09/20 KeyBanc
Corporate Office upgraded to Sector Weight from Underweight at KeyBanc
07/02/20 JPMorgan
Corporate Office Properties upgraded on minimal COVID impact at JPMorgan
07/02/20 JPMorgan
Corporate Office Properties upgraded to Overweight from Neutral at JPMorgan
OFC Corporate Office Properties
$26.20 /

+0.135 (+0.52%)

Earnings
Forma Therapeutics reports Q2 EPS ($4.58) vs. ($6.03) » 07:17
08/13/20
08/13
07:17
08/13/20
07:17
FMTX

Forma Therapeutics

$34.02 /

-0.56 (-1.62%)

Reports Q2 revenue $0,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMTX Forma Therapeutics
$34.02 /

-0.56 (-1.62%)

07/14/20 SVB Leerink
Forma Therapeutics initiated with an Outperform at SVB Leerink
07/14/20 Jefferies
Forma Therapeutics initiated with a Buy at Jefferies
07/14/20 Credit Suisse
Forma Therapeutics initiated with an Outperform at Credit Suisse
  • 19
    Jun
FMTX Forma Therapeutics
$34.02 /

-0.56 (-1.62%)

Recommendations
Lyft price target lowered to $40 from $52 at BTIG » 07:17
08/13/20
08/13
07:17
08/13/20
07:17
LYFT

Lyft

$30.58 /

-0.065 (-0.21%)

BTIG analyst Jake Fuller…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$30.58 /

-0.065 (-0.21%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

06:50 Today Stifel
Lyft price target lowered to $30 from $34 at Stifel
06:05 Today Jefferies
Near-term headwinds could impede quick recovery to Lyft stock, says Jefferies
08/10/20 Jefferies
Lyft price target lowered to $40 from $50 at Jefferies
08/10/20 Credit Suisse
Lyft price target lowered to $66 from $75 at Credit Suisse
LYFT Lyft
$30.58 /

-0.065 (-0.21%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

Downgrade
Progressive downgraded to Hold from Buy at Argus » 07:17
08/13/20
08/13
07:17
08/13/20
07:17
PGR

Progressive

$89.01 /

+0.06 (+0.07%)

Argus analyst Kevin Heal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGR Progressive
$89.01 /

+0.06 (+0.07%)

PGR Progressive
$89.01 /

+0.06 (+0.07%)

07/31/20 Erste
Progressive downgraded to Hold from Buy at Erste
07/16/20 Deutsche Bank
Progressive price target raised to $95 from $90 at Deutsche Bank
06/11/20
Fly Intel: Top five analyst downgrades
06/11/20 Piper Sandler
Progressive downgraded to Neutral from Overweight at Piper Sandler
PGR Progressive
$89.01 /

+0.06 (+0.07%)

PGR Progressive
$89.01 /

+0.06 (+0.07%)

Earnings
RedHill Biopharma reports Q2 EPS (4c), consenus (7c) » 07:16
08/13/20
08/13
07:16
08/13/20
07:16
RDHL

RedHill Biopharma

$9.18 /

+0.21 (+2.34%)

Reports Q2 revenue $21M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$9.18 /

+0.21 (+2.34%)

RDHL RedHill Biopharma
$9.18 /

+0.21 (+2.34%)

07/07/20 SMBC Nikko
RedHill Biopharma initiated with an Outperform at SMBC Nikko
02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
RDHL RedHill Biopharma
$9.18 /

+0.21 (+2.34%)

Hot Stocks
Heat Biologics reports preclinical data for gp96-based COVID-19 vaccine » 07:16
08/13/20
08/13
07:16
08/13/20
07:16
HTBX

Heat Biologics

$1.55 /

-0.3 (-16.22%)

Heat Biologics reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$1.55 /

-0.3 (-16.22%)

HTBX Heat Biologics
$1.55 /

-0.3 (-16.22%)

03/05/20 Maxim
Heat Biologics price target raised to $2 at Maxim after COVID-19 vaccine deal
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
02/06/20 Maxim
Heat Biologics initiated with a Buy at Maxim
Recommendations
Performance Food Group price target raised to $40 from $35 at BTIG » 07:15
08/13/20
08/13
07:15
08/13/20
07:15
PFGC

Performance Food Group

$33.53 /

-1.18 (-3.40%)

BTIG analyst Peter Saleh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFGC Performance Food Group
$33.53 /

-1.18 (-3.40%)

PFGC Performance Food Group
$33.53 /

-1.18 (-3.40%)

08/06/20 Credit Suisse
Performance Food Group assumed with an Outperform at Credit Suisse
07/16/20 BTIG
Performance Food Group initiated with a Buy at BTIG
05/05/20 Guggenheim
Performance Food risk/reward compelling with 50% upside, says Guggenheim
04/23/20 BMO Capital
Performance Food downgraded to Market Perform from Outperform at BMO Capital
PFGC Performance Food Group
$33.53 /

-1.18 (-3.40%)

  • 16
    Apr
  • 21
    Nov
PFGC Performance Food Group
$33.53 /

-1.18 (-3.40%)

PFGC Performance Food Group
$33.53 /

-1.18 (-3.40%)

Downgrade
Solaris Oilfield downgraded to Equal Weight at Wells Fargo » 07:15
08/13/20
08/13
07:15
08/13/20
07:15
SOI

Solaris Oilfield

$8.21 /

+0.155 (+1.93%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

07:01 Today Wells Fargo
Solaris Oilfield downgraded to Equal Weight from Overweight at Wells Fargo
05/04/20 Imperial Capital
Solaris Oilfield price target raised to $9 from $7 at Imperial Capital
04/15/20 Piper Sandler
Solaris Oilfield downgraded to Neutral from Overweight at Piper Sandler
04/14/20 Piper Sandler
Solaris Oilfield downgraded to Neutral from Overweight at Piper Sandler
SOI Solaris Oilfield
$8.21 /

+0.155 (+1.93%)

Earnings
MTBC sees FY20 revenue $105M-$107M, consensus $105.77M » 07:15
08/13/20
08/13
07:15
08/13/20
07:15
MTBC

MTBC

$12.14 /

-0.16 (-1.30%)

Sees adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTBC MTBC
$12.14 /

-0.16 (-1.30%)

MTBC MTBC
$12.14 /

-0.16 (-1.30%)

07/10/20 Benchmark
MTBC initiated with a Buy at Benchmark
07/08/20 B. Riley FBR
MTBC price target raised to $15.50 from $8.50 at B. Riley FBR
07/02/20 Roth Capital
MTBC initiated with a Buy at Roth Capital
06/22/20 H.C. Wainwright
MTBC upgraded to Buy from Neutral at H.C. Wainwright
MTBC MTBC
$12.14 /

-0.16 (-1.30%)

Earnings
MTBC, Inc reports Q2 EPS (65c), consensus (69c) » 07:14
08/13/20
08/13
07:14
08/13/20
07:14
MTBC

MTBC

$12.14 /

-0.16 (-1.30%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTBC MTBC
$12.14 /

-0.16 (-1.30%)

MTBC MTBC
$12.14 /

-0.16 (-1.30%)

07/10/20 Benchmark
MTBC initiated with a Buy at Benchmark
07/08/20 B. Riley FBR
MTBC price target raised to $15.50 from $8.50 at B. Riley FBR
07/02/20 Roth Capital
MTBC initiated with a Buy at Roth Capital
06/22/20 H.C. Wainwright
MTBC upgraded to Buy from Neutral at H.C. Wainwright
MTBC MTBC
$12.14 /

-0.16 (-1.30%)

Periodicals
Social media companies discuss misinformation ahead of U.S. election, WSJ says » 07:13
08/13/20
08/13
07:13
08/13/20
07:13
FB

Facebook

$259.71 /

+3.96 (+1.55%)

, GOOG

Alphabet

$1,506.55 /

+27.75 (+1.88%)

, GOOGL

Alphabet Class A

$1,506.83 /

+27.6 (+1.87%)

, TWTR

Twitter

$37.45 /

+0.165 (+0.44%)

Facebook (FB), Google…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$259.71 /

+3.96 (+1.55%)

GOOG Alphabet
$1,506.55 /

+27.75 (+1.88%)

GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

TWTR Twitter
$37.45 /

+0.165 (+0.44%)

FB Facebook
$259.71 /

+3.96 (+1.55%)

08/10/20 Truist
Trade Desk price target raised to $450 from $250 at Truist
08/10/20 Morgan Stanley
Pinterest upgraded to Overweight on social shopping trend at Morgan Stanley
08/10/20 Mizuho
Facebook price target raised to $315 from $285 at Mizuho
08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
GOOG Alphabet
$1,506.55 /

+27.75 (+1.88%)

08/12/20 JPMorgan
Broadcom likely co-designed Google's next-gen AI chip, says JPMorgan
08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

08/12/20 JPMorgan
Broadcom likely co-designed Google's next-gen AI chip, says JPMorgan
08/10/20 Truist
Trade Desk price target raised to $450 from $250 at Truist
08/10/20 RBC Capital
ADT Inc price target raised to $16 from $10 at RBC Capital
08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
TWTR Twitter
$37.45 /

+0.165 (+0.44%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 SunTrust
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
FB Facebook
$259.71 /

+3.96 (+1.55%)

GOOG Alphabet
$1,506.55 /

+27.75 (+1.88%)

GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

TWTR Twitter
$37.45 /

+0.165 (+0.44%)

FB Facebook
$259.71 /

+3.96 (+1.55%)

GOOG Alphabet
$1,506.55 /

+27.75 (+1.88%)

GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

TWTR Twitter
$37.45 /

+0.165 (+0.44%)

FB Facebook
$259.71 /

+3.96 (+1.55%)

GOOG Alphabet
$1,506.55 /

+27.75 (+1.88%)

GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

TWTR Twitter
$37.45 /

+0.165 (+0.44%)

FB Facebook
$259.71 /

+3.96 (+1.55%)

TWTR Twitter
$37.45 /

+0.165 (+0.44%)

GOOGL Alphabet Class A
$1,506.83 /

+27.6 (+1.87%)

Upgrade
Schlumberger upgraded to Overweight at Wells Fargo » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
SLB

Schlumberger

$20.35 /

+0.04 (+0.20%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

07:00 Today Wells Fargo
Schlumberger upgraded to Overweight from Equal Weight at Wells Fargo
07/27/20 Citi
Schlumberger upgraded to Buy from Neutral at Citi
07/16/20 Scotiabank
Schlumberger upgraded to Outperform from Sector Perform at Scotiabank
07/15/20 Cowen
Schlumberger upgraded to Outperform from Market Perform at Cowen
SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

SLB Schlumberger
$20.35 /

+0.04 (+0.20%)

Earnings
Azek sees Q4 revenue up 12%-17%, adj. EBITDA up 14%-19% » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
AZEK

Azek

$34.05 /

+0.57 (+1.70%)

AZEK is introducing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$34.05 /

+0.57 (+1.70%)

08/11/20 DA Davidson
Azek price target raised to $33 from $27 at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Citi
Azek initiated with a Neutral at Citi
07/07/20 B. Riley FBR
B. Riley FBR starts Azek at Buy with $38 price target
AZEK Azek
$34.05 /

+0.57 (+1.70%)

  • 12
    Jun
AZEK Azek
$34.05 /

+0.57 (+1.70%)

AZEK Azek
$34.05 /

+0.57 (+1.70%)

Hot Stocks
Akcea Therapeutics' Waylivra new pricing and reimbursement approved in Germany » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
AKCA

Akcea Therapeutics

$11.40 /

-0.12 (-1.04%)

Akcea Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKCA Akcea Therapeutics
$11.40 /

-0.12 (-1.04%)

AKCA Akcea Therapeutics
$11.40 /

-0.12 (-1.04%)

01/22/20 Stifel
Akcea LICA data look 'solid,' as expected, says Stifel
10/08/19 BMO Capital
Akcea Therapeutics price target lowered to $39 from $43 at BMO Capital
10/07/19 Stifel
Pfizer deal a 'solid, unexpected' win for Akcea Therapeutics, says Stifel
10/07/19
Akcea Therapeutics upgraded to Outperform on Pfizer partnership at Wells Fargo
AKCA Akcea Therapeutics
$11.40 /

-0.12 (-1.04%)

Upgrade
CAE upgraded to Outperform from Sector Perform at Scotiabank » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
CAE

CAE

/

+

Scotiabank analyst Konark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAE CAE
/

+

CAE CAE
/

+

07/27/20 RBC Capital
CAE price target lowered to C$28 from C$29 at RBC Capital
07/09/20 National Bank
CAE price target raised to C$25 from C$24 at National Bank
07/01/20
CAE downgraded to Neutral from Buy at BofA
07/01/20 BofA
CAE downgraded to Neutral from Buy at BofA
CAE CAE
/

+

Upgrade
Credicorp upgraded to Neutral from Underperform at BofA » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
BAP

Credicorp

/

+

BofA analyst Ernesto…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAP Credicorp
/

+

BAP Credicorp
/

+

08/06/20 Credit Suisse
Credicorp downgraded to Neutral from Outperform at Credit Suisse
06/24/20 Scotiabank
Credicorp downgraded to Sector Perform from Outperform at Scotiabank
06/24/20 Scotiabank
Credicorp downgraded to Sector Perform from Outperform at Scotiabank
06/23/20 Santander
Credicorp downgraded to Hold from Buy at Santander
Earnings
Hookipa Pharma reports Q2 EPS (28c), consensus (47c) » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
HOOK

Hookipa Pharma

$10.80 /

-0.17 (-1.55%)

Reports Q2 revenue $6.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HOOK Hookipa Pharma
$10.80 /

-0.17 (-1.55%)

HOOK Hookipa Pharma
$10.80 /

-0.17 (-1.55%)

09/27/19 H.C. Wainwright
Hookipa Pharma initiated with a Buy at H.C. Wainwright
HOOK Hookipa Pharma
$10.80 /

-0.17 (-1.55%)

HOOK Hookipa Pharma
$10.80 /

-0.17 (-1.55%)

Recommendations
Monster Beverage price target raised to $93 from $87 at Goldman Sachs » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
MNST

Monster Beverage

$82.68 /

+2.08 (+2.58%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$82.68 /

+2.08 (+2.58%)

MNST Monster Beverage
$82.68 /

+2.08 (+2.58%)

08/05/20 Jefferies
Monster Beverage price target raised to $90 from $73 at Jefferies
08/05/20 Deutsche Bank
Monster Beverage price target raised to $92 from $83 at Deutsche Bank
07/29/20 SunTrust
Monster Beverage price target raised to $85 from $65 at SunTrust
07/27/20 Stifel
Monster Beverage price target raised to $84 from $77 at Stifel
MNST Monster Beverage
$82.68 /

+2.08 (+2.58%)

MNST Monster Beverage
$82.68 /

+2.08 (+2.58%)

Hot Stocks
Tapestry CEO sees 'a return to sustained topline growth' in 2H21 » 07:12
08/13/20
08/13
07:12
08/13/20
07:12
TPR

Tapestry

$15.57 /

+0.03 (+0.19%)

Joanne Crevoiserat,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Goldman Sachs
Tapestry upgraded to Buy from Neutral at Goldman Sachs
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 HSBC
Tapestry upgraded to Buy from Hold at HSBC
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

Hot Stocks
Zentalis expects cash to fund operations into 2023 » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
ZNTL

Zentalis

$32.42 /

-1.49 (-4.39%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Guggenheim
Guggenheim starts Zentalis at Buy, sees ZN-c5 as potentially best-in-class
04/28/20 Morgan Stanley
Morgan Stanley starts Zentalis at Overweight with $45 price target
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

  • 30
    Jul
  • 03
    Apr
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

Earnings
Azek reports Q3 EPS (44c), consensus 10c » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
AZEK

Azek

$34.05 /

+0.57 (+1.70%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$34.05 /

+0.57 (+1.70%)

08/11/20 DA Davidson
Azek price target raised to $33 from $27 at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Citi
Azek initiated with a Neutral at Citi
07/07/20 B. Riley FBR
B. Riley FBR starts Azek at Buy with $38 price target
  • 12
    Jun
AZEK Azek
$34.05 /

+0.57 (+1.70%)

AZEK Azek
$34.05 /

+0.57 (+1.70%)

Earnings
Zentalis reports Q2 EPS (78c), consensus (50c) » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
ZNTL

Zentalis

$32.42 /

-1.49 (-4.39%)

"This quarter and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Guggenheim
Guggenheim starts Zentalis at Buy, sees ZN-c5 as potentially best-in-class
04/28/20 Morgan Stanley
Morgan Stanley starts Zentalis at Overweight with $45 price target
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

  • 30
    Jul
  • 03
    Apr
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

Upgrade
ECN Capital upgraded to Outperform from Sector Perform at RBC Capital » 07:09
08/13/20
08/13
07:09
08/13/20
07:09
ECNCF

ECN Capital

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECNCF ECN Capital
$0.00 /

+ (+0.00%)

ECNCF ECN Capital
$0.00 /

+ (+0.00%)

07/17/20 Raymond James
ECN Capital resumed with an Outperform rating at Raymond James
04/29/20 TD Securities
ECN Capital price target lowered to C$6 from C$7 at TD Securities
04/21/20 Scotiabank
ECN Capital price target lowered to C$4.50 from C$6 at Scotiabank
04/03/20 CIBC
ECN Capital downgraded to Neutral from Outperformer at CIBC

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.